Literature DB >> 32016033

Impact of circulating tumor DNA early detection and serial monitoring in the management of stage I to III colorectal cancer.

Diana Bello Roufai1, François-Clément Bidard1,2,3.   

Abstract

Entities:  

Year:  2019        PMID: 32016033      PMCID: PMC6976395          DOI: 10.21037/atm.2019.10.30

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


× No keyword cloud information.
  20 in total

1.  Reproducibility of a semiquantitative measurement of circulating DNA in plasma from neoplastic patients.

Authors:  Milo Frattini; Debora Balestra; Paolo Verderio; Gianfrancesco Gallino; Ermanno Leo; Gabriella Sozzi; Marco A Pierotti; Maria Grazia Daidone
Journal:  J Clin Oncol       Date:  2005-05-01       Impact factor: 44.544

Review 2.  Circulating tumor cells and circulating tumor DNA: What surgical oncologists need to know?

Authors:  L Cabel; C Proudhon; P Mariani; D Tzanis; G Beinse; I Bieche; J-Y Pierga; F-C Bidard
Journal:  Eur J Surg Oncol       Date:  2017-01-29       Impact factor: 4.424

3.  Clinical relevance of alterations in quantity and quality of plasma DNA in colorectal cancer patients: based on the mutation spectra detected in primary tumors.

Authors:  Jen-Kou Lin; Pei-Ching Lin; Chien-Hsing Lin; Jeng-Kai Jiang; Shung-Haur Yang; Wen-Yi Liang; Wei-Shone Chen; Shih-Ching Chang
Journal:  Ann Surg Oncol       Date:  2014-05-20       Impact factor: 5.344

4.  RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter study.

Authors:  J B Bachet; O Bouché; J Taieb; O Dubreuil; M L Garcia; A Meurisse; C Normand; J M Gornet; P Artru; S Louafi; F Bonnetain; A Thirot-Bidault; I Baumgaertner; R Coriat; D Tougeron; T Lecomte; F Mary; T Aparicio; L Marthey; V Taly; H Blons; D Vernerey; P Laurent-Puig
Journal:  Ann Oncol       Date:  2018-05-01       Impact factor: 32.976

5.  Direct detection of early-stage cancers using circulating tumor DNA.

Authors:  Jillian Phallen; Mark Sausen; Vilmos Adleff; Alessandro Leal; Carolyn Hruban; James White; Valsamo Anagnostou; Jacob Fiksel; Stephen Cristiano; Eniko Papp; Savannah Speir; Thomas Reinert; Mai-Britt Worm Orntoft; Brian D Woodward; Derek Murphy; Sonya Parpart-Li; David Riley; Monica Nesselbush; Naomi Sengamalay; Andrew Georgiadis; Qing Kay Li; Mogens Rørbæk Madsen; Frank Viborg Mortensen; Joost Huiskens; Cornelis Punt; Nicole van Grieken; Remond Fijneman; Gerrit Meijer; Hatim Husain; Robert B Scharpf; Luis A Diaz; Siân Jones; Sam Angiuoli; Torben Ørntoft; Hans Jørgen Nielsen; Claus Lindbjerg Andersen; Victor E Velculescu
Journal:  Sci Transl Med       Date:  2017-08-16       Impact factor: 17.956

6.  Clinical Implications of Monitoring Circulating Tumor DNA in Patients with Colorectal Cancer.

Authors:  Lone V Schøler; Thomas Reinert; Mai-Britt W Ørntoft; Christine G Kassentoft; Sigrid S Árnadóttir; Søren Vang; Iver Nordentoft; Michael Knudsen; Philippe Lamy; Ditte Andreasen; Frank V Mortensen; Anders R Knudsen; Katrine Stribolt; Kim Sivesgaard; Peter Mouritzen; Hans J Nielsen; Søren Laurberg; Torben F Ørntoft; Claus L Andersen
Journal:  Clin Cancer Res       Date:  2017-06-09       Impact factor: 12.531

7.  Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis.

Authors:  Thierry Lecomte; Anne Berger; Franck Zinzindohoué; Stéphanie Micard; Bruno Landi; Hélène Blons; Philippe Beaune; Paul-Henri Cugnenc; Pierre Laurent-Puig
Journal:  Int J Cancer       Date:  2002-08-10       Impact factor: 7.396

8.  Analysis of circulating tumor DNA to monitor metastatic breast cancer.

Authors:  Sarah-Jane Dawson; Dana W Y Tsui; Muhammed Murtaza; Heather Biggs; Oscar M Rueda; Suet-Feung Chin; Mark J Dunning; Davina Gale; Tim Forshew; Betania Mahler-Araujo; Sabrina Rajan; Sean Humphray; Jennifer Becq; David Halsall; Matthew Wallis; David Bentley; Carlos Caldas; Nitzan Rosenfeld
Journal:  N Engl J Med       Date:  2013-03-13       Impact factor: 91.245

9.  An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer.

Authors:  C G Moertel; T R Fleming; J S Macdonald; D G Haller; J A Laurie; C Tangen
Journal:  JAMA       Date:  1993-08-25       Impact factor: 56.272

Review 10.  Metastasis: from dissemination to organ-specific colonization.

Authors:  Don X Nguyen; Paula D Bos; Joan Massagué
Journal:  Nat Rev Cancer       Date:  2009-04       Impact factor: 60.716

View more
  2 in total

1.  Utility of tumor-informed circulating tumor DNA in the clinical management of gastrointestinal malignancies.

Authors:  Danielle Brazel; Priyanka Kumar; Liudmila N Schafer; Benjamin Eidenschink; Shannon Zhang; Maheswari Senthil; Farshid Dayyani
Journal:  J Gastrointest Oncol       Date:  2021-12

2.  Comprehensive analysis of 5-hydroxymethylcytosine in zw10 kinetochore protein as a promising biomarker for screening and diagnosis of early colorectal cancer.

Authors:  Yanqi Dang; Dan Hu; Jingjuan Xu; Chunlin Li; Yingjue Tang; Zhenhua Yang; Yang Liu; Wenjun Zhou; Li Zhang; Hanchen Xu; Yangxian Xu; Guang Ji
Journal:  Clin Transl Med       Date:  2020-07-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.